a public good project by the
Synthesis
Company
of California

© 2026

Richard J. Nowak | doi.page

0 works0 citations0 h-index

Richard J. Nowak

Yale University(US)

Publications by Year

Research Areas

Myasthenia Gravis and Thymoma, Peripheral Neuropathies and Disorders, Antifungal resistance and susceptibility, Parkinson's Disease and Spinal Disorders, Monoclonal and Polyclonal Antibodies Research

Most-Cited Works

→ α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular Protofibrils(2002)805 cited
→ Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study(2017)764 cited
→ Self-Assembly of Aβ₁_-₄₂into Globular Neurotoxins(2003)524 cited
→ Protofibrillar Islet Amyloid Polypeptide Permeabilizes Synthetic Vesicles by a Pore-like Mechanism that May Be Relevant to Type II Diabetes(2002)293 cited
→ Rituximab as treatment for anti-MuSK myasthenia gravis(2017)244 cited
→ Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis(2019)243 cited

→ Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis(2020)

188 cited

→ Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation(2005)168 cited

→ Response of patients with refractory myasthenia gravis to rituximab: a retrospective study(2011)155 cited

→ Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic(2020)154 cited